MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics.
about
MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2Chemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastomaSignificance and therapeutic value of miRNAs in embryonal neural tumorsInhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticlesDeep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma.miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAsMicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicityDeregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation.HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.Neuroblastoma: molecular pathogenesis and therapy.MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells.The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma.The role of MicroRNA in chemical carcinogenesis.Therapeutic targeting of miRNAs in neuroblastoma.New prognostic markers in neuroblastoma.The roles of microRNAs in neuroblastoma.Retinoic acid signaling and neuronal differentiation.Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours.Translating microRNAs into biomarkers: What is new for pediatric cancer?Identification of miRNAs contributing to neuroblastoma chemoresistanceMYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells.Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.A very rare adult case with neuroblastoma.Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice.MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression.miR-506 suppresses neuroblastoma metastasis by targeting ROCK1MiRNA Influences in Neuroblast Modulation: An Introspective Analysis.MicroRNAs and their predicted target messenger RNAs are deregulated by exposure to a carcinogenic dose of comfrey in rat liver.miRNA expression profile of bone marrow resident cells from children with neuroblastoma is not significantly different from that of healthy children.
P2860
Q21245700-C575F888-96A8-4191-A844-5B4C67CADAB7Q26800007-97A2FB73-E310-47E3-8658-1B7816881FBEQ26827171-3746AE08-B538-449F-B071-821674D75C1EQ27301841-A14CE63C-2786-4DEC-9E2D-210F8DE4B52CQ33577733-BE1EF4E3-192C-4976-99DC-95F832B950BAQ34099211-2D40C712-0C27-4D84-8E08-0E796EF7809DQ35178612-5D987A45-A726-48D4-88D6-02335A9ADA30Q35266342-A4F06622-1E5B-4E75-B0E5-33AB83FCCB82Q35510489-C76825F0-ABEA-4030-AD81-AB4DE9B3CAA2Q35562611-80CD9634-8F19-4782-A944-346E4D2954E7Q35564199-678A7137-62B0-4730-8D2C-CE6C0196EB39Q35907425-891365C9-9B68-4EDB-A52A-B9581D1A5D72Q36544990-B33D4261-97C3-4541-A8EA-26C7404E9A8CQ37041036-884CD95E-0E7E-4075-A9B1-87A4201BB786Q37457983-33C838B7-A67F-4A5B-B785-D03E0F114F67Q37765520-490F2398-7DFD-428B-A38E-1312BD78A889Q37775637-0DDCA07D-4BE6-4A16-AB34-06C848D755F8Q38088418-3949E407-3E58-46E8-BFD5-DC31349EE2CCQ38182012-A785247E-F656-41EE-B01D-C3F7A2047740Q38307264-E75CC39A-6CC2-4170-A8D1-55E2F8AAD02BQ38546133-7F77DE69-A79E-4308-BFA3-1C42A3E15EEAQ38768383-452A6E2B-5594-4ABB-A758-1246FCD143D6Q38810073-0CE86CA5-5F45-4B25-809A-0F817F52DF59Q38875079-60B7641B-553F-4C88-8C61-9090669DA31EQ39022048-967ADE7F-6764-43A4-8249-BD712BBEBC2DQ39201098-48D1DA2F-1D9E-4FBF-A80F-C4EE028F346EQ39230154-020FB2A3-962D-47F6-9808-13E6641F76C1Q39256459-4D6C4052-CA1D-4D3B-B4ED-7C12E9BB956BQ39534111-BEEDAB79-722F-4E6E-8FA2-2BC084AFE0EBQ39542401-79E2120F-348A-4369-9C37-C69A2C3D522BQ39712751-FA2251B6-3BF6-460F-8F50-696EC0DC72F4Q42329734-9F198F28-E8FD-4CCE-B0B5-EDBEA39574DFQ48284272-1E36C30C-8B57-43BF-8023-D527EDC26A3AQ51596712-2175FF80-4B09-42B6-BEA8-3FD0F97CD11BQ55403792-93565F5A-3A06-47A5-A73B-D7362DCE3195
P2860
MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@ast
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@en
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@nl
type
label
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@ast
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@en
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@nl
prefLabel
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@ast
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@en
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@nl
P2860
P1476
MicroRNA involvement in the pa ...... icroRNA mediated therapeutics.
@en
P2093
R L Stallings
P2860
P304
P356
10.2174/138161209787315837
P577
2009-01-01T00:00:00Z